Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03079713 : Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Clinical diagnosis of neovascular age related macular degeneration requiring anti-VEGF
intravitreal injection in the routine course of their care

Exclusion Criteria:

- History of endophthalmitis, prior ocular surgery except cataract surgery, globe
rupture, retinal detachment, neurotrophic keratopathy, a history of corneal epithelial
basement membrane dystrophy, recent corneal abrasion or trauma, history of infectious
keratitis, lower eyelid pathology, those with a previously documented hypersensitivity
to ophthalmic 5% povidone-iodine solution (Betadine; Alcon Labs, Fort Worth, TX) or
inability to grade pain using the pain scale, pregnant patients, institutionalized
patients (nursing home residents, prisoners), those with a history of diabetes
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03079713      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740